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Skeletal muscle regeneration relies on a pool of resi-
dent muscle stem cells called satellite cells (MuSCs).
Following injury-induced destruction of the myofib-
ers, quiescent MuSCs are activated and generate
transient amplifying progenitors (myoblasts) that
will fuse to form new myofibers. Here, we focus on
the canonical Wnt signaling pathway and find that
either conditional b-catenin disruption or activation
in adult MuSCs results in perturbation of muscle
regeneration. Using both in vivo and in vitro ap-
proaches, we observed that myoblasts lacking
b-catenin show delayed differentiation, whereas
myoblasts with constitutively active b-catenin un-
dergo precocious growth arrest and differentiation.
Transcriptome analysis further demonstrated that
Wnt/b-catenin signaling interacts with multiple path-
ways and, more specifically, TGF-b signaling.
Indeed, exogenous TGF-b2 stimulation restores the
regenerative potential of muscles with targeted
b-catenin disruption in MuSCs. We conclude that a
precise level of b-catenin activity is essential for
regulating the amplification and differentiation of
MuSC descendants during adult myogenesis.INTRODUCTION
Regeneration of the adult skeletal muscle tissue relies on a pool
of resident muscle stem cells located around myofibers called
satellite cells (muscle stem cells [MuSCs]) that express the
paired box transcription factor Pax7 (Seale et al., 2000). Upon
damage to the myofibers, quiescent MuSCs are activated and
give rise to a population of transient amplifying myoblasts ex-
pressing the basic helix-loop-helix (bHLH) transcription factorsCe
This is an open access article under the CC BY-NMyoD and/or Myf5 (Megeney et al., 1996; Gayraud-Morel
et al., 2007). Most of the myoblasts will then permanently exit
the cell cycle, express the bHLH transcription factor Myogenin,
and fuse to form new myofibers and regenerate the tissue,
whereas a sub-population will re-populate the MuSC niche
(Tedesco et al., 2010). In this process, signals from the local
microenvironment orchestrate myoblast activation and amplifi-
cation and control their myogenic fate choice (recently reviewed
in Yin et al. (2013). Our previous work highlighted that many Wnt
proteins are secreted during muscle regeneration and also
described an important role for non-canonical Wnt7a signals in
regulating MuSC symmetric expansion during muscle tissue
repair (Le Grand et al., 2009).
The canonical Wnt/b-catenin cascade is a critical regulator of
stem cell biology in many adult tissues (Clevers and Nusse,
2012). Wnt proteins bind to receptors of the Frizzled and
low-density lipoprotein receptor-relayed protein (LRP) families
on the cell surface of receiving cells (MacDonald et al., 2009).
When Frizzled/LRP receptors are not engaged, b-catenin is
phosphorylated by a cytoplasmic destruction complex com-
posed of Axin, adenomatous polyposis coli (APC), casein
kinase I (CKI), and GSK3b. Phosphorylated b-catenin is ubiquiti-
nated and targeted for rapid destruction by the proteasome.
Upon receptor activation by Wnt ligands, Axin is recruited to
the phosphorylated tail of LRP. Recent data show that, through
this relocalization, the Wnt signal leads to inhibition of b-catenin
ubiquitination, which normally occurs within the complex. Sub-
sequently, the complex becomes saturated by the phosphory-
lated form of b-catenin, leading newly synthesized b-catenin to
accumulate and translocate to the nucleus (Li et al., 2012). Nu-
clear b-catenin forms a complex with the TCF transcription fac-
tors to activate transcription of Wnt target genes. However, the
mechanisms by which canonical Wnt proteins provoke specific
cellular responses and regulate muscle progenitor cell biology
remain poorly understood.
To date, conflicting reports proposed distinct roles for the ca-
nonical Wnt/b-catenin pathway during skeletal muscle regener-
ation. An earlier work implicated the Wnt1/b-catenin pathway inll Reports 15, 1277–1290, May 10, 2016 ª 2016 The Authors 1277
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muscle cell differentiation through activation and recruitment of
MuSC-like reserve myoblasts for fusion with myotubes in vitro
(Rochat et al., 2004). In contrast, a second set of in vitro exper-
iments showed that Wnt/b-catenin signaling promotes MuSC
proliferation in the first stages of their activation on isolated my-
ofibers in vitro (Otto et al., 2008). Canonical Wnt signaling has
also been implicated in promoting cultured myoblast myogenic
potential through inhibition of Myostatin activity (Bernardi et al.,
2011). When assessed in vivo, injection of recombinant Wnt pro-
teins to a regenerating adult muscle appeared to control
myogenic lineage progression by limiting Notch signaling and
thus promoting differentiation in the later stages of muscle
regeneration (Brack et al., 2008). Intriguingly, in vivo experiments
suggested that canonical Wnt signaling is not required for mus-
cle regeneration or satellite cell self-renewal (Murphy et al.,
2014). In contrast, we recently showed that APC expression by
MuSCs is required to dampen canonical Wnt signaling and allow
cell-cycle progression (Parisi et al., 2015).
To address these issues and to comprehensively understand
the roles of Wnt/b-catenin signals during muscle regeneration,
we interrogated the regenerative capacity of skeletal muscle
with either MuSC-specific b-catenin gain-of-function or loss-
of-function mutations. Strikingly, we observed that, in both con-
ditional mouse models, the fate of muscle progenitor cells was
perturbed and that skeletal muscles were unable to regenerate
properly following acute damage. We found that myoblasts fail
to differentiate in the absence of b-catenin and that the genetic
activation of the canonical Wnt pathway pushes myoblasts to-
ward differentiation at the expense of amplification in vitro as
well as in vivo. A Wnt/b-catenin-dependent transcriptome anal-
ysis identified the upregulation of, among others, the TGF-b
pathway. We further demonstrate that forced TGF-b pathway
activation, ex vivo and in vivo, can bypass the requirement of
myoblasts for b-catenin to differentiate. Our results indicate
that an adequate level of intrinsic Wnt/b-catenin signaling is
essential within MuSC descendants for their function during tis-
sue repair.
RESULTS
Conditional Targeted b-catenin Gene Disruption in
MuSCs
Previous work has demonstrated that adult MuSCs and myo-
blasts express b-catenin. To reproduce these results, we per-
formed immunohistochemical analysis of b-catenin expression
on tissue sections of regenerating (7 days post-injury [d.p.i])
and regenerated (30 d.p.i) tibialis anterior (TA) muscle tissues us-
ing an antibody recognizing the C-terminal part of b-catenin. We
observed that Myogenin+ and MyoD+ muscle progenitor cells
express b-catenin in vivo (Figure S1A). To further evaluate b-cat-
enin activation during adult myogenesis, we performed immuno-
cytochemical analysis of single myofibers isolated from extensor
digitorum longus (EDL) muscles using an antibody specifically
recognizing the active forms of b-catenin (un-phosphorylated
on Ser33/37 and Thr41). We observed that quiescent MuSCs
stained immediately after isolation express only very low levels
of active b-catenin proteins. Doublets of dividing MuSCs on
cultured myofibers exhibited mainly cytoplasmic localization of1278 Cell Reports 15, 1277–1290, May 10, 2016active b-catenin proteins when scored 42 hr after isolation (Fig-
ure S1B). Interestingly, foci of nuclear active b-catenin proteins
were observed in MuSC descendants after 72 hr in culture
ex vivo, at the time MuSCs undergo fate choice decision.
Co-immunostaining of active b-catenin with Pax7 (to mark
undifferentiated muscle progenitor cells) or Myogenin (to label
differentiating muscle progenitor cells) indicated that b-catenin
signaling is mainly active during differentiation (Figure S1C).
These data are consistent with our previous analysis of the Wnt
reporter allele Axin2LacZ that was not detected in uninjured mus-
cles but strongly marked myogenin-expressing differentiating
cells during muscle regeneration (Parisi et al., 2015).
To address the function of b-catenin in adult MuSCs and
their progeny in vivo, we crossed mice with either the
b-cateninExons2-6-Lox (Brault et al., 2001) or b-cateninExon3-Lox
(Harada et al., 1999) conditional allele with mice expressing a
tamoxifen (TAM)-inducible Cre recombinase estrogen receptor
fusion protein, CreERT2, in cells that express Pax7 (Lepper
et al., 2009). While the deletion of b-catenin exons 2–6 results
in expression of an inactive protein (loss of function, conditional
knockout [cKO]), the deleted protein fragment encoded by
b-catenin exon 3 contains the GSK3b phosphorylation target
serine/threonine residues necessary for ubiquitination. Thus,
the resulting protein is constitutively active (CA, gain of function).
To induce recombination at the conditional b-catenin loci,
we injected 8-week-old mice of the following genotypes with
TAM diluted in corn oil: Pax7CreERT2/+ (controls), Pax7CreERT2/+::
b-cateninEx3lox/+ (b-catenin CA), and Pax7CreERT2/+::
b-cateninEx2-6lox/lox (b-catenin cKO) (Figure 1A). For controls,
we also injected b-catenin cKO mice with corn oil. The efficacy
and specificity of TAM-induced Cre activity was confirmed by
92% labeling of MuSCs one week following TAM administration
in Pax7CreERT2 mice crossed with Rosa26 reporter (R26R) mice
(as described previously and repeated in our hands; data not
shown). To evaluate the recombination efficiency at the protein
level, we used the antibody recognizing the total b-catenin
(C-terminal) for b-catenin cKO mice because the recombined
allele cannot generate a functional protein (Figure 1B) and the
antibody recognizing the non-phospho (active) b-catenin for
b-catenin CA mice (Figure 1C) because the epitope is absent
from the constitutively active protein when exon3 is deleted.
Immunostaining on isolated myofibers further validated the
recombination of targeted loci in MuSCs of b-catenin cKO and
b-catenin CA mice 1 week after TAM administration (Figure 1D).
Because b-catenin protein could be very stable in quiescent
MuSCs, we sorted MuSCs from b-catenin cKO and CA mice
by fluorescence-activated cell sorting (FACS) (Figure 1F), plated
them in vitro for 48 hr to allow them to exit quiescence, and per-
formed genotyping PCR for the conditional b-catenin alleles. As
shown in Figure 1G, the deleted alleles can only be amplified in
MuSCs from TAM-treated mice, and we could not detect the
non-recombined alleles in b-catenin cKO and b-catenin CA
MuSCs anymore. We used fibro-adipogenic progenitors (FAPs)
sorted by FACS as an internal control to validate the tissue spec-
ificity of the Pax7CreERT2/+ allele. Mice with conditional genetic
disruption of either b-catenin allele did not show any overt phe-
notypes, and uninjured muscle appeared normal 1 month after
TAM injection (data not shown). Quiescent MuSCs were not
Figure 1. Conditional Targeted b-Catenin
Gene Disruption in MuSCs
(A) Genotypes of the mice used in the study.
(B and C) Isolated single myofibers of control,
b-catenin cKO (B), and b-catenin CA (C) animals
7 days after TAM-induced recombination of tar-
geted loci in MuSCs. Recombination in Pax7+ cells
of b-catenin cKO animals was confirmed by using
an antibody that recognizes the C-terminal part of
b-catenin. Recombination in Pax7+ cells of b-cat-
enin CA animals was confirmed by using an anti-
body that recognizes an epitope encoded by exon
3 that is non-phosphorylated when b-catenin is
active.
(D) Quantification of b-catenin-positive MuSCs on
isolated single myofibers.
(E) Numbers of Pax7-positive cells in uninjured TA
muscles1monthafter TAM-induced recombination.
(F) FACS profiles of mononuclear cells derived
from control (CTR), b-catenin cKO, and b-catenin
CA muscles 1 week after TAM injection. The pro-
files were gated for CD31-neg, CD45-neg, and
Ter119-neg fractions. FAPs are fibro-adipogenic
progenitors cells. VCAM-PE, vascular cell adhe-
sion molecule.
(G) Genotyping PCRs of MuSCs sorted by FACS.
For the b-catenin-exon2-6-lox locus, the PCR
product of the deleted allele is longer than the flox
allele, whereas the PCR product of the WT allele is
shorter than the flox allele (left). For the b-catenin-
exon3-Lox locus, the PCR product of the deleted
allele is shorter than the WT allele, whereas the
PCR product of the WT allele is shorter than the
flox allele (right). FAP cells and H2O were used as
negative controls.
Scale bars, 20 mm. n = 3 mice for each genotype.
Values are mean ± SEM. ***p < 0.001.affected by b-catenin gain or loss of function because the num-
ber of sub-laminar Pax7-expressing cells was unchanged in
b-catenin cKO and b-catenin-CA mice compared with control
mice 1 month following induction of Cre activity (Figure 1E).
Modulation of b-Catenin Signaling in Adult MuSCs
Impairs Muscle Regeneration
To determine whether b-catenin-conditional mutant MuSCs can
support damage-induced myogenesis, we injected cardiotoxinCell R(CTX) into the TA muscle of TAM-treated
control, b-catenin cKO, and b-catenin
CA mice and sampled the injured tissue
at different time points for histological
analysis (Figure 2A). 4 d.p.i, regenerating
tissues from all genotypes were com-
posed of early regenerating myotubes
and numerous mononucleated cells
(likely proliferating myoblasts and infil-
trating immune cells) and did not
show overt phenotypes or abnormalities.
7 d.p.i, regenerating control muscles
were already composed of newly formed
myofibers with centrally located myonu-clei, whereas b-catenin cKO and b-catenin CAmuscles also con-
tained a higher amount of fibrotic tissue and inflammatory cells.
30 d.p.i, control muscle had fully regenerated and muscle archi-
tecture was restoredwith normalmyofiber hypertrophy, whereas
b-catenin cKO and b-catenin CA muscles presented aberrant
myofiber morphology and atrophy (Figure 2B).
To further visualize and quantify the differences in the regener-
ative process between control and b-catenin cKO/CA mice, we
performed immunostaining for Laminin to visualize the myofibereports 15, 1277–1290, May 10, 2016 1279
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basal lamina on 30-d.p.i muscle cryosections (Figure 2C). We
first observed that b-catenin cKO and CA regenerated tissue
sections contained more myofibers per field, suggesting smaller
myofibers in mutant regenerated tissues, compared with
controls (Figure 2D). We then determined the myofiber cross-
sectional area (CSA). Representation of myofiber size distribu-
tion demonstrated that the proportion of small myofibers was
significantly increased in b-catenin cKO and CA mice compared
with control mice, whereas the proportion of myofibers with a
higher CSA was decreased (Figure S2A). Calculation of the
meanmyofiber diameter further validated that regenerated myo-
fibers were significantly smaller in both b-catenin cKO and CA
tissues compared with control muscles (Figure 2E). Surprisingly,
the size and weight of injured muscles were not altered in b-cat-
enin cKO or CA mice compared with controls (Figure S2B; data
not shown). This is explained by the increase in the total number
of myofibers per TA muscle in both b-catenin cKO/CA mice
compared with controls (Figure S2C). We next quantified the
numbers of sub-laminar Pax7+ cells (Figure 2F) and observed
that, although b-catenin gene disruption in MuSCs does not per-
turb the renewal of the MuSC niche, b-catenin CA regenerated
muscle contained a reduced MuSC pool (Figure 2G). Of note,
no differences were observed in the numbers of MyoD+ cells
in regenerated muscles between controls and b-catenin cKO/
CA mice (data not shown).
Defects or delays in the muscle-regenerative process are
frequently associated with aberrant extracellular matrix (ECM)
remodeling. To visualize the connective tissue, we performed
immunostaining for collagen type I (Figure S2D). Quantification
of the total collagen-positive areas revealed that both mutant
mouse strains exhibited extensive deposition of connective tis-
sue (Figure 2H). Interestingly, the number of ER-TR7+ fibroblasts
increased 3-fold in b-catenin cKOmice, whereas their proportion
increased only slightly in b-catenin CA muscles (Figure S2E),
suggesting that the cellular mechanisms responsible for aberrant
ECM remodeling are different between the two mutant mice.
These experiments demonstrate that correct levels of b-catenin
expression and activation are critical for MuSC function in adult
skeletal muscle.
b-Catenin Controls Muscle Progenitor Cell Dynamics
during Muscle Regeneration
To further understand the alterations in the regenerative process
in mice with targeted b-catenin mutations in MuSCs, we
analyzed the early regeneration process at 7 d.p.i (Figure 3A).Figure 2. Conditional Modulation of b-Catenin Function in MuSCs Imp
(A) Experimental setup. TAM was injected into mice on 4 consecutive days. TA m
following injury.
(B) H&E staining on cryosections of uninjured and regenerating muscle tissue at 4,
number of inflammatory cells between the smaller myofibers in both conditional
(C) Anti-Laminin staining on cryosections of regenerated TA muscles in control,
(D) Quantification of the number of myofibers per field.
(E) Regenerated muscles of conditional mutant mice are composed of smaller m
(F) Anti-Pax7 and anti-Laminin staining on cryosections of regenerated TA musc
(G) Quantification of the number of sublaminar Pax7+ cells per field.
(H) Quantification of the collagen-covered area in regenerated TA muscles of co
Scale bars, 50 mm (B and C) and 25 mm (F). n = 4 mice/genotype. Values are meAt this point, both b-catenin cKO and b-catenin CA muscles
were already composed of smaller new myofibers compared
with control muscles (Figures 3B and 3C). In addition, the num-
ber of myonuclei per regenerated myofiber in b-catenin cKO
muscles was reduced compared with control muscles when
quantified at 7 and 30 d.p.i. (Figure 3D). Interestingly, the
number of myonuclei per myofiber was comparable with con-
trols in b-catenin CA mice at 7 d.p.i. but was significantly
reduced compared with controls at the end of tissue regenera-
tion. These results suggest an alteration in the differentiation/
fusion process in b-catenin cKO muscles and an exhaustion of
the myogenic progenitor pool at later time points in b-catenin
CA muscles.
To further validate our hypothesis, we quantified the numbers
of proliferating (Pax7-expressing) and differentiating (Myogenin-
expressing) muscle progenitors in regenerating muscles at
7 d.p.i. (Figure 3G). Strikingly, we observed a reduction in b-cat-
enin cKO muscles and a strong augmentation in b-catenin CA
muscles of differentiating Myogenin+ myocytes (Figure 3E). At
the same time, the number of proliferating, Pax7+ myoblasts in
b-catenin CA muscles was reduced, whereas b-catenin cKO
muscles did not show significant differences in the number of
Pax7+ cells compared with controls (Figure 3F). We then per-
formed immunostaining for the embryonic forms of myosin
heavy chain (eMHC), which marks all newly formed myofibers
between 3 and 5 days post-injury and which is downregulated
when the myofiber matures (Figure 3H). Control muscles only
contained a very limited number of eMHC-positive myofibers,
whereas b-catenin cKO muscles contained a high number of
lagged myofibers expressing eMyHC (Figure 3I), suggesting a
delay in the regeneration process in the absence of b-catenin
expression in MuSCs. The proportion of lagged myofibers was,
however, only slightly increased in b-catenin CA muscles
compared with controls (Figure 3I). In summary, our results indi-
cate that the state of b-catenin in MuSC descendants regulates
the timing of myogenic progenitor cell differentiation during tis-
sue repair in vivo.
Delayed Differentiation of b-Catenin cKO Myoblasts
Observation of muscle tissue regeneration in our mouse models
suggested that b-catenin intrinsically regulates the balance be-
tween proliferation and differentiation in MuSC descendants.
To further validate these results, we cultured MuSCs sorted by
FACS from b-catenin cKO mice that had been subjected to
TAM. We let the MuSCs proliferate to give rise to primaryairs Proper Muscle Regeneration
uscles were injured by a single CTX injection and analyzed at different times
7, and 30 d.p.i in control, b-catenin cKO, and b-catenin CAmice. Note the high
mutant muscles.
b-catenin cKO, and b-catenin CA mice at 30 d.p.i.
yofibers.
les in control, b-catenin cKO, and b-catenin CA mice at 30 d.p.i.
ntrol, b-catenin cKO, and b-catenin CA mice.
an ± SEM. *p < 0.05, **p < 0.01, ***p < 0.001. n.s., not significant.
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Figure 3. b-Catenin Controls the Proliferation/Differentiation Balance in Muscle Progenitor Cells In Vivo
For a Figure360 author presentation of Figure 3, see the figure online at http://dx.doi.org/10.1016/j.celrep.2016.04.022#mmc3.
(A) Experimental setup. TAM was injected into mice on 4 consecutive days. TA muscles were injured by a single CTX injection and analyzed at 7 d.p.i.
(B) Anti-Laminin staining of TA muscle cryosections. Note that early regenerating myofibers were smaller in diameter in b-catenin cKO mice than in controls,
whereas both small and normally sized myofibers were present in b-catenin CA animals.
(C) Distribution of myofiber CSAs at 7 d.p.i.
(D) Mean numbers of myonuclei per regenerating myofiber at 7 and 30 d.p.i. Conditional mutant mice show reduced myonuclei numbers compared with
control mice.
(E) Numbers of Myogenin-positive (differentiating) cells in control and conditional mutant regenerating muscles at 7 d.p.i.
(F) Numbers of Pax7-positive (proliferating) cells in control and conditional mutant regenerating muscles at 7 d.p.i. (normalized by the number of Pax7-positive
cells in the contralateral leg).
(legend continued on next page)
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Figure 4. b-Catenin Is Required for Primary Myoblast Differentiation
Primary myoblasts were expanded from b-catenin cKO MuSCs sorted by FACS and cultured for two passages.
(A) Confirmation of b-catenin exon 2-6 deletion, which is generated in mutant cells at the DNA level. The flox-deleted allele could be amplified by PCR on isolated
DNA ofmyoblasts derived from TAM-treated b-catenin cKOmice, and the flox allele could not be detected anymore. Myoblasts derived from TAM-treated control
mice and corn oil-treated b-catenin cKO mice were used as negative controls.
(B) Immunocytochemistry and quantification of b-catenin expression in primary myoblasts using an antibody that recognizes the b-catenin C-terminal part.
(C) b-catenin cKO and control myoblasts have similar BrdU incorporation rates.
(D) qRT-PCR of myogenic genes of control and b-catenin cKO primary myoblasts under proliferating conditions.
(E) Myogenin immunocytochemistry and proportion of Myogenin-positive cells after 24 hr under differentiating conditions of control and b-catenin cKO primary
myocytes.
(F) Myosin heavy chain (MyHC) immunocytochemistry and proportion of nuclei incorporated inmyotubes (fusion index) after 72 hr under differentiating conditions
of control and b-catenin cKO primary myocytes.
Scale bars, 50 mm. n = 3 primary cell cultures. Values are mean ±SEM. *p < 0.05, **p < 0.01.myoblasts for two passages and validated b-catenin gene dele-
tion by genotyping PCR. As shown in Figure 4A, the deleted allele
was detected only in b-catenin cKOmyoblasts and not in control
myoblasts or in myoblasts derived from b-catenin cKOmice that(G) Anti-Myogenin staining of regenerating TA cryosections in control and condi
outside the newly forming myofibers under control and mutant conditions.
(H) Lagging myofibers expressing eMHCs were present in regenerating muscles
(I) Proportion of lagged, eMHC-expressing myofibers in controls and b-catenin c
Scale bars, 50 mm. n = 4 mice/genotype. Values are mean ± SEM. *p < 0.05, **phad not been treated with TAM. Immunostaining for b-catenin
proteins showed that 97% of the b-catenin cKO myoblasts do
not express b-catenin (Figure 4B). Similarly, qRT-PCR analysis
demonstrated a complete absence of b-catenin expression attional mutant mice at 7 d.p.i. revealed the number of differentiating myocytes
of b-catenin cKO mice and, to a lower extent, in b-catenin CA animals.
KO and b-catenin CA regenerating TA muscles at 7d.p.i.
< 0.01, ***p < 0.001.
Cell Reports 15, 1277–1290, May 10, 2016 1283
the transcript level in b-catenin cKO myoblasts (Figure 4D).
Interestingly, b-catenin cKO myoblasts did not exhibit any
perturbation in their proliferation potential, as shown by BrdU
incorporation assays (Figure 4C). In contrast, quantification of
myogenic gene expression demonstrated that, although b-cate-
nin cKO myoblasts express similar Pax7 transcript levels
compared with controls, they express a lower amount of MyoD
andMyogenin transcripts, suggesting that they may be less effi-
cient in their differentiation potential (Figure 4D). To test this
hypothesis, we induced the myoblasts to differentiate and quan-
tified a lower proportion of Myogenin+ myocytes in b-catenin
cKO cultures compared with controls (Figure 4E). After 3 days
in differentiation medium, b-catenin cKO cells gave rise to
smaller myotubes containing fewer nuclei compared with control
cells (Figure 4F). Our data indicate that b-catenin controls
myogenic progenitor cell differentiation.
Impaired Proliferation and Precocious Differentiation of
b-Catenin CA Myoblasts
We next tried to grow b-catenin CA primary myoblasts from
MuSCs sorted by FACS, but we observed that these cells imme-
diately differentiated after plating in vitro (42% Myogenin+ cells
after 48 hr and 94% Myogenin+ cells after 72 hr in vitro; data
not shown). This phenotype led us to grow primary myoblasts
from b-catenin CA mice that were not subjected to TAM and to
perform exon 3 deletion in vitro. Recombination of b-catenin
exon 3 was efficiently induced in vitro by treating the cultures
with 1 mM 4-hydroxy-tamoxifen (Figures 5A and 5B). In this
case, we observed that genetic activation of b-catenin signaling
lead to a decrease in BrdU incorporation in primary myoblasts
(Figure 5C). This was accompanied by a strong upregulation
of canonical Wnt target Axin2 and Wisp1 transcription, a
downregulation of Pax7 and MyoD as well as of the cell-cycle
regulator Chek1, and a strong induction ofMyogenin expression
in primarymyoblasts (Figure 5D). Furthermore, we could observe
that the number of Myogenin and embryonic-MHC positive cells
24 hr after shifting to differentiation medium increased 3-fold
when 4-hydroxy-tamoxifen had been applied to myoblasts (Fig-
ure 5E). In summary, our findings indicate that activation of
b-catenin signaling in myoblasts causes cells to switch from pro-
liferation to growth arrest and differentiation independently of the
muscle microenvironment.
Identification of b-Catenin-Dependent Genes in Muscle
Progenitor Cells
To identify genes that become transcribed following activation of
theWnt/b-catenin pathway inmuscle cells, we performedmicro-
array analysis of genetically disrupted b-catenin CA primary
myoblasts compared with control cells (GEO: GSE72496). We
observed that the transcription of many genes implicated in
cell cycle and proliferation was significantly downregulated
when the canonical Wnt pathway was constitutively active,
whereas the transcription of many genes implicated in muscular
development and function was upregulated (Figure 6A). Interest-
ingly, genes encoding structural components of skeletal myofib-
ers (identified under the category ‘‘muscular disorders and
myopathies’’) were also downregulated, suggesting that accel-
eration of the myogenic process in vitro perturbs normal muscle1284 Cell Reports 15, 1277–1290, May 10, 2016cell maturation. We found that, when canonical Wnt signaling
was activated, known Wnt target genes, along with components
of the pathway itself, like Porcupine, Frizzled1, and Nkd1,
become transcribed (Figure 6B). Furthermore, we observed
that gene expression of other signaling pathways was also acti-
vated; i.e., components of the bone morphogenetic protein
pathway, the Akt1/target of rapamycin (TOR) pathway, and the
TGF-b pathway. We validated the upregulation of gene expres-
sion of some genes found in the array by qRT-PCR (Figure 6C).
Because a mutation in the TGF-b3 gene has been recently impli-
cated in failed postnatal muscle growth (Rienhoff et al., 2013), we
were interested in the signaling crosstalk of canonical Wnt and
TGF-b signaling pathways. We first validated that Wnt3a treat-
ment resulted in elevated phosphorylation of the TGF-b down-
stream effector proteins Smad2/3 in proliferating myoblasts
(Figure 6D). Our microarray data indicated that TGF-b2 and
TGF-b3 expression was elevated in primary myoblasts with the
activated Wnt/b-catenin pathway, and we verified that both
TGF-bs0 expression levels increased in b-catenin CA myoblasts
as well as in wild-type proliferating and differentiating myoblasts
when treated with Wnt3a by qRT-PCR (Figures 6E and 6F; data
not shown). Accordingly, TGF-b2 and TGF-b3 expression was
downregulated in b-catenin cKO myoblasts and in myoblasts
treated with the Porcupine inhibitor LGK974 compared with con-
trol cells (Figures 6E and 6F). Taken together, these results
indicate that activation of canonical Wnt/b-catenin signaling in
myoblasts results in broad transcriptional changes associated
with myogenic differentiation, including premature cell-cycle
exit, precocious differentiation, and perturbed muscle cell differ-
entiation. Furthermore, we identify the TGF-b pathway as a po-
tential effector of Wnt/b-catenin in adult muscle progenitor cells.
Activation of the TGF-b Pathway Restores the Ability of
Myoblasts to Differentiate in b-Catenin cKO Animals
A recent report demonstrated that TGF-b2 was induced in
response to elevated canonical Wnt signaling in dystrophic mus-
cles and that the resulting increase in TGF-b activity lead to the
conversion of dystrophic MuSCs to fibrogenic cells (Biressi
et al., 2014). In contrast, we did not observe any changes in
the expression of pro-fibrotic genes in our microarray data,
and we further validated that activation of canonical Wnt
signaling in healthy MuSCs descendants derived from non-
dystrophic skeletal muscle tissue does not lead to increased
expression of the Col1a1 and Col1a2 genes (Figure S3A). Addi-
tionally, treatment of control primary myoblasts with Wnt3a
proteins during the course of myogenic differentiation did not
lead to an increase in the proportion of non-myogenic cells in
cell culture (Figure S3B). These results suggest that the Wnt/
TGFb2 axis does not act similarly in healthy and dystrophic mus-
cle progenitors.
To understand the role of the TGF-b signaling pathway down-
stream of canonical Wnt signaling in MuSCs, we used the single
myofiber assay. In this experimental setup, single myofibers
from the EDL are carefully dissected out and cultured under
‘‘floating conditions.’’ Under these conditions, MuSCs become
activated and proliferate on the surface of their host myofibers,
generating clusters of amplifying progeny after 72 hr in culture
(Figure 7A). At this time, MuSCs descendants either maintain
Figure 5. Activation of b-Catenin Signaling in Proliferating Primary Myoblasts Promotes Growth Arrest and Myogenic Differentiation
Primary myoblasts were prepared from untreated b-catenin CA mouse muscles.
(A) Confirmation of b-catenin exon 3 deletion, which generates a constitutively active b-catenin, in mutant cells at the DNA and protein levels. The flox-deleted
allele could be amplified by PCR on isolated DNA of 4-hydroxy-tamoxifen (Tamo)-treated myoblasts, and a protein of smaller size could be detected by western
blot. The amount of wild-type non-phosphorylated b-catenin was diminished in Tamo-treated cells compared with mock-treated cells.
(B) Immunocytochemistry and quantification of Tamo-treated and mock-treated b-catenin CA primary myoblasts using a b-catenin antibody that recognizes the
protein fragment encoded by exon 3 (non-phospho active b-catenin).
(C) Myoblasts with constitutively active b-catenin do not incorporate BrdU.
(D) qRT-PCR of Wnt targets, cell-cycle regulators, and myogenic genes of Tamo-treated and mock-treated b-catenin CA primary myoblasts under proliferating
conditions.
(E) Myogenin immunocytochemistry and proportion of Myogenin and eMHC-positive cells after 24 hr under differentiating conditions of Tamo-treated or mock-
treated b-catenin CA primary myocytes.
Scale bars, 50 mm. n = 3 primary cell cultures. Values are mean ± SEM. *p < 0.05, **p < 0.01, ***p < 0.001.the progenitor state (Pax7+) or start to differentiate (Myogenin+).
As expected, LGK974 treatment lead to a diminution of the pro-
portion of Myogenin+ cells compared with control conditions
(Figure 7B). TGF-b2 addition alone to the culture medium didnot change the proportion of Myogenin-expressing cells
(although cells appeared more dispersed around their host
myofiber). Strikingly, co-treatment of single myofibers with
both LGK974 and TGF-b2 completely restored the proportionCell Reports 15, 1277–1290, May 10, 2016 1285
Figure 6. TGFb Signaling Is Induced in Primary Myoblasts with Conditionally Activated b-Catenin
(A) Ingenuity pathway analysis of biological functions with their subcategories significantly (p < 0.05) activated (Z score > 2) or inhibited (Z score < 2) in Tamo-
treated b-catenin CA myoblasts compared with mock-treated b-catenin CA myoblasts.
(B) Heatmap representation of the changes in selected gene expression levels in TAM-treated compared with mock-treated b-catenin CA primary myoblasts in
three independent experiments (each row is normalized to have mean zero, variance one).
(C) qRT-PCR of Wnt target genes of Tamo-treated and mock-treated b-catenin CA primary myoblasts under proliferating conditions.
(D) Activation of the canonical Wnt/b-catenin pathway in primary myoblasts by recombinant Wnt3a proteins results in phospho-Smad2/3 accumulation.
(legend continued on next page)
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Figure 7. TGF-b2 Addition Rescues Myogenic Differentiation in MuSCs Deficient for Wnt/b-catenin Signaling
(A) Single EDL myofibers were cultured ex vivo for 3 days under different conditions, fixed, and stained with Pax7 and Myogenin antibodies.
(B) Inhibition of Wnt secretion by LGK974 leads to a blockade in Myogenin expression compensated by TGF-b2 addition.
(C) Schematic of rescue experiments in TAM-treated control and b-catenin cKOmice. TA muscles were injured by a single CTX injection, recombinant TGF-b2 or
saline solution was injected at 3 d.p.i., and muscles were analyzed at 7 d.p.i.
(D) Immunostaining for Laminin and Myogenin proteins on cryosections from 7 d.p.i regenerating TA muscles.
(E) Quantification of the number of Myogenin-expressing cells per 100 myofibers. Exogenous TGF-b2 allows for MuSCs to differentiate in the absence of
endogenous canonical Wnt signaling.
Scale bars, 25 mm (A) and 50 mm (E). n = 3 mice/condition. Values are mean ± SEM. *p < 0.05.of Myogenin-expressing cells to control-treated ones. These
results suggest that activation of TGF-b signaling downstream
of b-catenin controls the balance between proliferation and dif-
ferentiation in muscle progenitor cells (Figure 7B).
We next testedwhether activation of the TGF-bpathway in vivo
could compensate for the loss of b-catenin in MuSCs during
regeneration and could bypass the failure of myoblasts to differ-
entiate in b-catenin cKO animals. To this aim, we injected recom-
binant TGF-b2 protein into the TA of control and b-catenin cKO
animals on day 3 of regeneration (Figure 7C). We observed that
the number of Myogenin-positive myocytes outside the forming
myofibers at 7 d.p.i. was significantly increased in b-catenin
cKOanimalswhen treatedwith TGF-b2 in comparisonwith b-cat-(E) Relative expression levels of TGF-b2 in proliferating, control, b-catenin cKO, an
treated with recombinant Wnt3a proteins or the Porcupine inhibitor LGK974, res
(F) Relative expression levels of TGFb3 in proliferating, control, b-catenin cKO and
treated with recombinant Wnt3a proteins or the Porcupine inhibitor LGK974, res
n = 3 primary cell cultures. Values are mean ± SEM. *p < 0.05, **p < 0.01, ***p <enin cKOanimals thatwereadministeredsaline. Indeed, thenum-
ber of Myogenin+ myocytes in TGF-b2-treated b-catenin cKO
mice was not significantly different from the number of myocytes
in control animals (Figures 7D and 7E).Moreover, myofiberswere
bigger and the tissue regenerated better in TGF-b2-injected
b-catenin cKO animals than in saline-injected b-catenin cKO an-
imals (Figure 7E; data not shown). These results suggest that
exogenous TGF-b2 leads to a rescue of the proliferation/differen-
tiation balance in myoblasts lacking b-catenin. From these data,
we conclude that the Wnt/b-catenin signaling pathway in muscle
progenitor cells activates the TGF-b pathway, which in turnmod-
ulates their proliferation and differentiation to help orchestrate
restoration of the injured skeletal muscle to its original size.d TAM-treated b-catenin CAmyoblasts and inwild-type proliferatingmyoblasts
pectively.
TAM-treated b-catenin CA myoblasts and inwild-type proliferating myoblasts
pectively.
0.001.
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DISCUSSION
Postnatal myogenesis is executed by a pool of adult stem cells,
MuSCs. Upon injury to the tissue, MuSCs receive signals from
their stem cell niche and microenvironment to be activated, pro-
liferate, and give rise to muscle progenitor cells that will differen-
tiate to fuse to their host myofibers or to each other to generate
new muscle fibers de novo. Here we show that the canonical
Wnt/b-catenin pathway is required by MuSC progeny during
skeletal muscle regeneration. We found that, in mice with
MuSC-specific b-catenin gain-of-function and loss-of-function
mutations, muscle regeneration was disturbed following acute
injury. Muscle progenitor cells with targeted b-catenin gene
disruption differentiate less efficiently, whereas conditional acti-
vation of b-catenin pushed muscle progenitor cells prematurely
toward differentiation.
During skeletal muscle development, Pax3/7+ myogenic pro-
genitors arise from the mesoderm and are maintained as a
proliferating population that sustains successive phases of myo-
genesis (Relaix et al., 2005). Canonical Wnt signaling has been
shown to regulate both embryonic and fetal myogenesis. b-cat-
enin activity is required for the maintenance of the epithelial
structure of somites (Linker et al., 2005) and further for driving
Myf5 expression in the somite expaxial domain in cells that will
form the myotome (Borello et al., 2006). In the embryonic limb,
different Wnt signals control myogenic differentiation (Anakwe
et al., 2003), and, more specifically, b-catenin intrinsically con-
trols fetal progenitor number as well as myofiber number and
type (Hutcheson et al., 2009). The latter observations in the em-
bryo agree well with our findings, suggesting that adult and fetal
muscle progenitor cells share a requirement for b-catenin.
Previous work suggested that activation of canonical Wnt/
b-catenin signaling in muscle cells is a necessary step for
commitment to terminal differentiation (Zhuang et al., 2014),
possibly by counteracting Notch (Brack et al., 2008) andMyosta-
tin (Bernardi et al., 2011). Moreover, it has been shown that tar-
geted recombination of the b-catenin transcriptional co-factors
Bcl9 and Bcl9.2 in MuSCs inhibited the normal regenerative
response of skeletal muscle (Brack et al., 2009).We demonstrate
here that b-catenin function in adult myoblasts is crucial for their
full regenerative potential to effectively repair skeletal muscle tis-
sue after injury. Both our cell biology and transcriptome ap-
proaches validated that canonical Wnt signaling controls the
proper timing of cell-cycle arrest and of the expression of differ-
entiation markers by muscle progenitor cells both in vivo and
in vitro.
Surprisingly, Murphy et al. (2014) recently used genetic ap-
proaches similar to ours but did not observe any obvious differ-
ences in the regenerative capacity of skeletal muscles with
MuSCs homozygous for the deleted b-cateninEx2-6lox/lox allele
in comparison to MuSCs heterozygous for b-catenin. In our
hands, the regeneration deficits of both b-catenin cKO and
b-catenin CA muscle were highly reproducible. There are multi-
ple explanations for these discrepancies. First, it is possible
that the use of b-catenin heterozygous mice as controls may
already cause a regeneration phenotype and thus reduce the
differences with conditional b-catenin-null mice. Second, tar-
geted b-catenin recombination was not evaluated at the single1288 Cell Reports 15, 1277–1290, May 10, 2016cell level but by FACS onMuSCs sorted from regenerating tissue
byMurphy et al. (2014). It is possible that ‘‘escaper cells’’ already
contributed to injury-induced myogenesis during the initial
phases of regeneration. Third, the Pax7CreERT2 mice used by
Murphy et al. (2014) are not the same as we used, and it is well
known that recombination efficiencies varies between different
strains of mice. A high escaper ratio in conditional null MuSCs
in the previous study could explain the absence of a regeneration
phenotype. Importantly, our results are consistent with data ob-
tained by injecting recombinant Wnt3a protein (Brack et al.,
2008) or electroporating a Wnt3a expression plasmid (Le Grand
et al., 2009) into regenerating muscles, which both perturbed
muscle tissue repair.
Our transcriptome analysis allowed the identification of other
signaling pathways regulated by b-catenin in primary myoblasts.
We focused on TGF-b signaling because this pathway is known
to regulatemuscle progenitor behavior andmuscle regeneration.
As such, mutation in the TGF-b3 gene has been shown to cause
failed muscle growth after birth (Rienhoff et al., 2013). Further to
that point, genetic disruption of Smad7 (Cohen et al., 2015) or
Smad3 (Ge et al., 2012) in mice impairs muscle regeneration
and leads to impairedmyoblast differentiation in a similar fashion
as the b-catenin cKO phenotype we report here. We observed
that canonical Wnt signaling controlled the expression of both
TGF-b2 and TGF-b3 in muscle progenitor cells and that injection
of exogenous TGF-b2 during muscle regeneration was able to
restore the ability of b-catenin cKO myoblasts to differentiate
in vivo. We thus define TGF-b pathway activation in MuSCs de-
scendants, downstream of canonical Wnt signaling, as a neces-
sary step for muscle tissue repair.
In contrast, the Wnt/TGFb2 axis was recently reported as be-
ing altered in dystrophic mdx mouse muscles (Biressi et al.,
2014). In the diseased model of Duchenne muscular dystrophy,
both canonical Wnt and TGF-b2 signaling are chronically
elevated in the muscle tissue. In this pathological context,
continuous Wnt/TGFb2 signals alter the muscle progenitor cell
fate and lead to a significant proportion of theMuSCs losing their
myogenic identity. However, we did not observe any changes in
‘‘fibrogenic’’ gene expression in myoblasts treated with Wnt3a
proteins or with constitutively active b-catenin. In our hands,
activation of canonical Wnt signaling in healthy muscle cells re-
sulted in accelerated myogenic differentiation. Both results are
not contradictory and can be explained in two ways. First, it is
possible that MuSCs of a healthy or a dystrophic environment
intrinsically respond differently to canonical Wnt and/or TGF-b
signals. It would be interesting to compare the transcriptomes
as well as b-catenin and SMAD2/3 whole-genome occupancy
in muscle progenitor cells from healthy and dystrophic muscle.
Second, we think that the observed differences could be related
to the duration of extrinsic signal reception by muscle cells in
different environments. A short and high Wnt/TGFb pulse during
skeletal muscle repair will not have the same effect compared
with continuous but low Wnt/TGF-b systemic signaling.
We propose that a tight control of intrinsic b-catenin activity in
MuSC progeny is required for their function within the skeletal
muscle tissue. We delineated that either loss of b-catenin func-
tion or unscheduled b-catenin activity in muscle progenitor cells
leads to defects in muscle regeneration that resemble a
pathological state (smaller myofibers, enhanced fibrosis, etc.).
To that point, mis-regulation of canonical Wnt signaling has
been reported in multiple muscle pathologies, such as fascio-
scapulohumeral muscular dystrophy (Block et al., 2013), oculo-
pharyngeal muscular dystrophy (Abu-Baker et al., 2013), and
Duchenne muscular dystrophy (Trensz et al., 2010). Our findings
represent a significant advance in our understanding of MuSC
biology and muscle regeneration. Future experiments will inves-
tigate the utility of modulating the canonical Wnt/b-catenin
pathway in vivo toward ameliorating the loss of muscle function
in neuromuscular disease.
EXPERIMENTAL PROCEDURES
Mice and In Vivo Cre Activation
Animals were handled according to European Community guidelines, and ex-
periments were performed in accordance with the guidelines of the French
Veterinary Department and approved by the University Paris-Descartes Ethical
Committee for Animal Experimentation. b-catenin-Exon2-6lox/lox (Brault et al.,
2001) and b-catenin-Exon3lox/wt mice (Harada et al., 1999) (both provided
by Sabine Colnot, Institut Cochin) were crossed to Pax7CreERT2 (Lepper
et al., 2009) mice (provided by Margaret Buckingham, Institut Pasteur). Pro-
genitors were checked by genotyping as described before. Comparisons
were made between age-matched littermates. To induce targeted gene
disruption, 200 ml of TAM (20 mg/ml in corn oil, Sigma) was applied intraperi-
toneally on four subsequent days to 8-week-old mice with an average weight
of 20 g.
Skeletal Muscle Injury
30 ml of CTX (12 mM in saline, Latoxan) was injected into hindlimb TA muscles
to induce injury, and mice were euthanized 4, 7, and 30 days afterward. Re-
combinant mouse TGF-b2 (R&D Systems) was diluted in 4 mM HCl/saline at
10 ng/ml, and 25ml was injected into the TA on day 3 of regeneration. Muscles
were freshly frozen in Tissue-Tek CRYO-OCT compound (Fisher Scientific)
and cut in cryostat sections of 10 mm.
Cell Culture
For single myofiber preparation, EDL muscles were dissected from hindlimbs,
and myofibers were isolated and cultured like described before (Le Grand
et al., 2012). Primary myoblasts were expanded from MuSCs sorted by
FACS for b-catenin cKO mice (Pax7CreERT2*b-catenin-exon2-6lox/lox) or ex-
tracted from limb muscles using the pre-plate technique for b-catenin CA
mice (Pax7CreERT2*b-catenin-exon3lox/+). Primary myoblasts were cultured on
collagen-coated dishes as described previously (Le Grand et al., 2012). Prolif-
eration medium consisted of Ham’s F-10 with 20% FBS (Eurobio), 2 ng/ml
basic fibroblast growth factor (FGF) (R&D Systems), and 1%penicillin/strepto-
mycin (Pen/Strep) (Life Technologies). To induce ex vivo targeted gene disrup-
tion, medium containing 4-hydroxy-tamoxifen (Sigma) at 1 mM was applied to
low-passage b-catenin CA cells on 3 consecutive days, and cells were used for
experiments after 3 more days. For differentiating conditions, cells were
seeded at 20,000 cells/cm2 on 1mg/ml Matrigel matrix (Corning Life Sciences)
in differentiation medium consisting of DMEM with 2% horse serum (Sigma)
and 1% Pen/Strep (Life Technologies) and were analyzed after 24 hr. Recom-
binant mouse Wnt3a was applied to wild-type myoblasts at 50 ng/ml, and
LGK974 Porcupine inhibitor (StemRD) was added at 2 mM.
Reverse Transcription and qPCR
RNA was isolated from TAM-treated and control cells with TRIzol reagent. Af-
ter subsequent DNase treatment, cDNA was generated using a high-capacity
reverse transcription kit (Ambion/Life Technologies). qPCR using LightCycler
480 SYBR Green Master Mix (Roche) was run in LC480 and performed in dou-
blets (see Table S1 for the primer pairs sequences). Transcripts levels were
determined by absolute quantification using a four-point standard curve. Rela-
tive gene expression was calculated by normalization against the TBP and
Cyclophilin reference genes.Immunostaining
H&E staining of muscle cryosections was performed according to standard
procedures. For fluorescent antibody staining, cryosections were fixed with
4%paraformaldehyde and permeabilized with 0.5% Triton X-100 (Sigma) prior
to unmasking with antigen unmasking solution (Vector Laboratories) at 95C
for 15 min and blocking with 5% BSA/2% goat serum for 1 hr. Cryosections
were incubated overnight with primary antibodies at 4C. Primary myoblasts
were fixed with 4% paraformaldehyde, permeabilized with 0.2% Triton
X-100, blocked with 2% goat serum, and incubated with primary antibodies
for 1 hr. For proliferation studies, cells were incubatedwith 30mMbromodeox-
yuridine (BrdU) (Sigma) for 40min and fixed and treatedwith 2NHCl for 20min.
DyLight-conjugated secondary antibodies (Abcam) were applied at 1:1,000,
nuclei were counterstained with DAPI at 0.5 mg/ml, and sections and cells,
respectively, were mounted in Dako mounting medium. See Table S1 for the
primary antibody list.
Microscopy and Statistics
Labeling was visualized by epifluorescent illumination using a Macroscope
AZ100 (Nikon). Quantification of muscle fiber sizes and the collagen-covered
areawere performedwith ImageJ (http://imagej.nih.gov/ij/). Pictures were pro-
cessed with Adobe Photoshop CS6. Histological analyses were conducted on
at least three different animals per genotype. Experiments with cells were per-
formed independently at least three times in duplicates. Statistics were
performed with GraphPad Prism 6. All values are expressed as mean ±
SEM. Significance between two groups was determined by unpaired Stu-
dent’s t tests, and significance betweenmultiple groupswas determined using
paired Student’s t tests. p < 0.05 was considered statistically significant.
ACCESSION NUMBERS
The accession number for the expression data reported in this paper is GEO:
GSE72496.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
three figures, and three tables and can be found with this article online at
http://dx.doi.org/10.1016/j.celrep.2016.04.022.
AUTHOR CONTRIBUTIONS
F.L.G. and A.R. conceived the experiments. A.R. performedmost of the exper-
iments. E.S., L.G., A.P., and F.L.G. also generated the experimental data. E.S.
revised the manuscript. F.L.G., E.S., and A.R. analyzed the data. C.L provided
the Pax7Cremice.M.M.T. provided the b-catenin-Exon3mice. F.L.G. and A.R.
generated the figures. F.L.G. wrote the manuscript. All authors corrected the
manuscript.
ACKNOWLEDGMENTS
We thank P.Maire, T. Cheung, and S. Ait-Si-Ali for critical reading of the manu-
script. We thank S. Jacques and F. Dumont of the Cochin Institute genomic fa-
cility for technical and bioinformatics assistance. We acknowledge B. Durel
and P. Bourdoncle of the Cochin Imaging Facility. E. Vezin and C. Gigaud pro-
vided technical help and support. This work was supported by funding from
the INSERM, the CNRS, the Agence National de la Recherche (ANR Jeune
Chercheur, Project RPV13010KKA), the Association Franc¸aise contre les My-
opathies, and E-Rare/ERANET. A.P. was supported by Ph.D. fellowships from
the Ministe`re de la Recherche et de l’Enseignement and from the Fondation
ARC pour la Recherche sur le Cancer. E.S. was supported by a post-doctoral
fellowship from Labex WhoAmI.
Received: October 7, 2015
Revised: February 8, 2016
Accepted: March 31, 2016
Published: April 28, 2016Cell Reports 15, 1277–1290, May 10, 2016 1289
REFERENCES
Abu-Baker, A., Laganiere, J., Gaudet, R., Rochefort, D., Brais, B., Neri, C.,
Dion, P.A., and Rouleau, G.A. (2013). Lithium chloride attenuates cell death
in oculopharyngeal muscular dystrophy by perturbingWnt/b-catenin pathway.
Cell Death Dis. 4, e821.
Anakwe, K., Robson, L., Hadley, J., Buxton, P., Church, V., Allen, S., Hart-
mann, C., Harfe, B., Nohno, T., Brown, A.M.C., et al. (2003). Wnt signalling reg-
ulates myogenic differentiation in the developing avian wing. Development
130, 3503–3514.
Bernardi, H., Gay, S., Fedon, Y., Vernus, B., Bonnieu, A., and Bacou, F. (2011).
Wnt4 activates the canonical b-catenin pathway and regulates negatively
myostatin: functional implication in myogenesis. Am. J. Physiol. Cell Physiol.
300, C1122–C1138.
Biressi, S., Miyabara, E.H., Gopinath, S.D., Carlig, P.M.M., and Rando, T.A.
(2014). A Wnt-TGFb2 axis induces a fibrogenic program in muscle stem cells
from dystrophic mice. Sci. Transl. Med. 6, 267ra176.
Block, G.J., Narayanan, D., Amell, A.M., Petek, L.M., Davidson, K.C., Bird,
T.D., Tawil, R., Moon, R.T., and Miller, D.G. (2013). Wnt/b-catenin signaling
suppresses DUX4 expression and prevents apoptosis of FSHD muscle cells.
Hum. Mol. Genet. 22, 4661–4672.
Borello, U., Berarducci, B., Murphy, P., Bajard, L., Buffa, V., Piccolo, S., Buck-
ingham, M., and Cossu, G. (2006). The Wnt/beta-catenin pathway regulates
Gli-mediated Myf5 expression during somitogenesis. Development 133,
3723–3732.
Brack, A.S., Conboy, I.M., Conboy, M.J., Shen, J., and Rando, T.A. (2008).
A temporal switch from notch to Wnt signaling in muscle stem cells is neces-
sary for normal adult myogenesis. Cell Stem Cell 2, 50–59.
Brack, A.S., Murphy-Seiler, F., Hanifi, J., Deka, J., Eyckerman, S., Keller, C.,
Aguet, M., and Rando, T.A. (2009). BCL9 is an essential component of canon-
ical Wnt signaling that mediates the differentiation of myogenic progenitors
during muscle regeneration. Dev. Biol. 335, 93–105.
Brault, V., Moore, R., Kutsch, S., Ishibashi, M., Rowitch, D.H., McMahon, A.P.,
Sommer, L., Boussadia, O., and Kemler, R. (2001). Inactivation of the beta-cat-
enin gene by Wnt1-Cre-mediated deletion results in dramatic brain malforma-
tion and failure of craniofacial development. Development 128, 1253–1264.
Clevers, H., and Nusse, R. (2012). Wnt/b-catenin signaling and disease. Cell
149, 1192–1205.
Cohen, T.V., Kollias, H.D., Liu, N., Ward, C.W., and Wagner, K.R. (2015). Ge-
netic disruption of Smad7 impairs skeletal muscle growth and regeneration.
J. Physiol. 593, 2479–2497.
Gayraud-Morel, B., Chre´tien, F., Flamant, P., Gome`s, D., Zammit, P.S., and
Tajbakhsh, S. (2007). A role for the myogenic determination gene Myf5 in adult
regenerative myogenesis. Dev. Biol. 312, 13–28.
Ge, X., Vajjala, A., McFarlane, C., Wahli, W., Sharma, M., and Kambadur, R.
(2012). Lack of Smad3 signaling leads to impaired skeletal muscle regenera-
tion. Am. J. Physiol. Endocrinol. Metab. 303, E90–E102.
Harada, N., Tamai, Y., Ishikawa, T., Sauer, B., Takaku, K., Oshima, M., and
Taketo, M.M. (1999). Intestinal polyposis in mice with a dominant stable muta-
tion of the beta-catenin gene. EMBO J. 18, 5931–5942.
Hutcheson, D.A., Zhao, J., Merrell, A., Haldar, M., and Kardon, G. (2009). Em-
bryonic and fetal limb myogenic cells are derived from developmentally
distinct progenitors and have different requirements for beta-catenin. Genes
Dev. 23, 997–1013.
Le Grand, F., Jones, A.E., Seale, V., Scime`, A., and Rudnicki, M.A. (2009).
Wnt7a activates the planar cell polarity pathway to drive the symmetric expan-
sion of satellite stem cells. Cell Stem Cell 4, 535–547.
Le Grand, F., Grifone, R., Mourikis, P., Houbron, C., Gigaud, C., Pujol, J., Mail-
let, M., Page`s, G., Rudnicki, M., Tajbakhsh, S., and Maire, P. (2012). Six11290 Cell Reports 15, 1277–1290, May 10, 2016regulates stem cell repair potential and self-renewal during skeletal muscle
regeneration. J. Cell Biol. 198, 815–832.
Lepper, C., Conway, S.J., and Fan, C.-M. (2009). Adult satellite cells and em-
bryonic muscle progenitors have distinct genetic requirements. Nature 460,
627–631.
Li, V.S.W., Ng, S.S., Boersema, P.J., Low, T.Y., Karthaus, W.R., Gerlach, J.P.,
Mohammed, S., Heck, A.J.R., Maurice, M.M., Mahmoudi, T., and Clevers, H.
(2012). Wnt signaling through inhibition of b-catenin degradation in an intact
Axin1 complex. Cell 149, 1245–1256.
Linker, C., Lesbros, C., Gros, J., Burrus, L.W., Rawls, A., and Marcelle, C.
(2005). beta-Catenin-dependent Wnt signalling controls the epithelial organi-
sation of somites through the activation of paraxis. Development 132, 3895–
3905.
MacDonald, B.T., Tamai, K., and He, X. (2009). Wnt/beta-catenin signaling:
components, mechanisms, and diseases. Dev. Cell 17, 9–26.
Megeney, L.A., Kablar, B., Garrett, K., Anderson, J.E., and Rudnicki, M.A.
(1996). MyoD is required for myogenic stem cell function in adult skeletal mus-
cle. Genes Dev. 10, 1173–1183.
Murphy, M.M., Keefe, A.C., Lawson, J.A., Flygare, S.D., Yandell, M., and Kar-
don, G. (2014). Transiently active Wnt/b-catenin signaling is not required but
must be silenced for stem cell function during muscle regeneration. Stem
Cell Reports 3, 475–488.
Otto, A., Schmidt, C., Luke, G., Allen, S., Valasek, P., Muntoni, F., Lawrence-
Watt, D., and Patel, K. (2008). Canonical Wnt signalling induces satellite-cell
proliferation during adult skeletal muscle regeneration. J. Cell Sci. 121,
2939–2950.
Parisi, A., Lacour, F., Giordani, L., Colnot, S., Maire, P., and Le Grand, F.
(2015). APC is required for muscle stem cell proliferation and skeletal muscle
tissue repair. J. Cell Biol. 210, 717–726.
Relaix, F., Rocancourt, D., Mansouri, A., and Buckingham, M. (2005). A Pax3/
Pax7-dependent population of skeletal muscle progenitor cells. Nature 435,
948–953.
Rienhoff, H.Y., Jr., Yeo, C.-Y., Morissette, R., Khrebtukova, I., Melnick, J., Luo,
S., Leng, N., Kim, Y.-J., Schroth, G., Westwick, J., et al. (2013). A mutation in
TGFB3 associated with a syndrome of low muscle mass, growth retardation,
distal arthrogryposis and clinical features overlapping with Marfan and
Loeys-Dietz syndrome. Am. J. Med. Genet. A. 161A, 2040–2046.
Rochat, A., Fernandez, A., Vandromme, M., Mole`s, J.-P., Bouschet, T., Car-
nac, G., and Lamb, N.J.C. (2004). Insulin and wnt1 pathways cooperate to
induce reserve cell activation in differentiation and myotube hypertrophy.
Mol. Biol. Cell 15, 4544–4555.
Seale, P., Sabourin, L.A., Girgis-Gabardo, A., Mansouri, A., Gruss, P., and
Rudnicki, M.A. (2000). Pax7 is required for the specification of myogenic sat-
ellite cells. Cell 102, 777–786.
Tedesco, F.S., Dellavalle, A., Diaz-Manera, J., Messina, G., and Cossu, G.
(2010). Repairing skeletal muscle: regenerative potential of skeletal muscle
stem cells. J. Clin. Invest. 120, 11–19.
Trensz, F., Haroun, S., Cloutier, A., Richter, M.V., and Grenier, G. (2010).
A muscle resident cell population promotes fibrosis in hindlimb skeletal mus-
cles of mdx mice through the Wnt canonical pathway. Am. J. Physiol. Cell
Physiol. 299, C939–C947.
Yin, H., Price, F., and Rudnicki, M.A. (2013). Satellite cells and themuscle stem
cell niche. Physiol. Rev. 93, 23–67.
Zhuang, L., Hulin, J.-A., Gromova, A., Tran Nguyen, T.D., Yu, R.T., Liddle, C.,
Downes, M., Evans, R.M., Makarenkova, H.P., and Meech, R. (2014). Barx2
and Pax7 have antagonistic functions in regulation of wnt signaling and satel-
lite cell differentiation. Stem Cells 32, 1661–1673.
